
A restructuring of Novo Nordisk will see it completely drop its inflammatory disorders activities in favour of concentrating on its …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

